Mount Sinai Lab Paves the Way for a New Era of Therapeutic Solutions for Thyroid Disease
With the publication of two 2024 studies, the Mount Sinai team led by Terry F. Davies, MD, continued to expand understanding of the physiologic mechanisms of Graves’ disease, as well as of thyroid eye disease, which about a third of people with Graves’ disease will develop.